Age-related Macular Dengeration (AMD) is the leading cause of blindness in the developed world, and though effective treatments are available for the wet AMD, they are currently lacking for the more-prevalent dry form. The researchers at Massachusetts Eye and Ear Infirmary found evidence that treatment with high-dose atorvastatin (80mg) is associated with regression of lipid deposits and improvement in visual acuity, without progression to advanced disease, in high-risk AMD patients. You can read more about it here.
- A Message from the President
- Researchers Discover Body’s Own Proteins Could Regrow Beta Cells